Ardent Health (NYSE:ARDT) Price Target Cut to $12.00 by Analysts at Mizuho

Ardent Health (NYSE:ARDT) had its price objective decreased by Mizuho from $20.00 to $12.00 in a report issued on Thursday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Mizuho’s price objective would suggest a potential upside of 34.00% from the company’s current price.

Other research analysts have also issued research reports about the stock. JPMorgan Chase & Co. decreased their price target on shares of Ardent Health from $15.00 to $12.00 and set a “neutral” rating on the stock in a research report on Monday, November 24th. Royal Bank Of Canada cut their target price on Ardent Health from $21.00 to $16.00 and set an “outperform” rating on the stock in a research report on Friday, November 14th. The Goldman Sachs Group began coverage on Ardent Health in a report on Tuesday, October 14th. They set a “neutral” rating and a $19.00 target price for the company. UBS Group began coverage on Ardent Health in a research note on Wednesday, September 10th. They issued a “buy” rating and a $17.00 price target on the stock. Finally, Morgan Stanley reissued an “equal weight” rating and set a $12.00 target price (down from $22.00) on shares of Ardent Health in a research note on Friday, November 14th. Six investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $14.92.

Ardent Health Price Performance

Shares of NYSE ARDT opened at $8.96 on Thursday. Ardent Health has a twelve month low of $8.28 and a twelve month high of $17.34. The company has a current ratio of 2.08, a quick ratio of 1.95 and a debt-to-equity ratio of 0.67. The firm has a 50-day moving average of $11.70 and a two-hundred day moving average of $12.45. The company has a market capitalization of $1.28 billion, a price-to-earnings ratio of 6.18, a PEG ratio of 7.35 and a beta of 0.77.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings data on Wednesday, November 12th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.10. Ardent Health had a net margin of 3.24% and a return on equity of 19.02%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.55 billion. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. As a group, analysts expect that Ardent Health will post 1.23 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Ardent Health

Several institutional investors and hedge funds have recently modified their holdings of ARDT. Vanguard Group Inc. boosted its position in Ardent Health by 368.9% during the first quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company’s stock valued at $18,296,000 after purchasing an additional 1,046,845 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after purchasing an additional 724,841 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Ardent Health by 75.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock valued at $22,332,000 after buying an additional 703,739 shares during the last quarter. SageView Advisory Group LLC lifted its holdings in shares of Ardent Health by 367.2% during the 2nd quarter. SageView Advisory Group LLC now owns 790,663 shares of the company’s stock valued at $10,800,000 after buying an additional 621,430 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC acquired a new position in Ardent Health in the third quarter worth approximately $6,377,000.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.